Pantoprazole
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Acid Reflux Disease
Conditions
Acid Reflux Disease, Obstructive Sleep Apnea
Trial Timeline
Aug 1, 2004 → Aug 1, 2006
NCT ID
NCT00307944About Pantoprazole
Pantoprazole is a approved stage product being developed by Pfizer for Acid Reflux Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT00307944. Target conditions include Acid Reflux Disease, Obstructive Sleep Apnea.
What happened to similar drugs?
3 of 11 similar drugs in Acid Reflux Disease were approved
Approved (3) Terminated (3) Active (6)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (9)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00744419 | Phase 1 | Completed |
| NCT00367614 | Phase 3 | Completed |
| NCT00383916 | Phase 1 | Completed |
| NCT00362609 | Phase 3 | Completed |
| NCT00868296 | Phase 3 | Completed |
| NCT00307944 | Approved | Completed |
| NCT00133770 | Approved | Completed |
| NCT00040495 | Phase 3 | Completed |
| NCT00037570 | Phase 2 | Completed |
Competing Products
20 competing products in Acid Reflux Disease